Skip to main content
. 2017 Dec 27;61(4):405–410. doi: 10.1515/jvetres-2017-0062

Table 5.

IgM contents (g/L) in blood sera of each group

Groups Ingredient concentration Drug control PCV2 control Blank control
10 mg/kg 5 mg/kg 1 mg/kg 10 mg/kg 105TCID50 -
SSA 0.93 ± 0.13 0.84 ± 0.24 0.79 ± 0.21 0.87 ± 0.1    
SSD 1.0 ± 0.18 0.85 ± 0.14 0.76 ± 0.14 0.9 ± 0.14    
PNS 0.88 ± 0.18 0.82 ± 0.11 0.77 ± 0.13 0.75 ± 0.1 0.82 ± 0.09 0.67 ± 0.11
SR1 0.87 ± 0.13 0.8 ± 0.19 0.83 ± 0.18 0.85 ± 0.15    
AB4 0.96 ± 0.11 0.91 ± 0.25 0.85 ± 0.05 0.83 ± 0.12    

Data shown are mean (± SD) g/L

Value significantly different from PCV2 control group at * P < 0.05